1 |
Miyahara M. Tanuma JI. Sugihara K et al : Tumor Iymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma. Cancer. 2007 Sep 15:110(6): 1287-1294.
DOI
ScienceOn
|
2 |
Grandi C, Alloisio M, Moglia D et al : Prognostic significance of lymphatic spread in head and neck carcinomas: Therapeutic implications. Head Neck Surg 8 : 67, 1985.
DOI
ScienceOn
|
3 |
O-charoenrat P, Rhys-Evans P, Eccles SA : Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis. Cancer 92 : 556, 2001.
DOI
ScienceOn
|
4 |
Neuchrist C, Erovic BM, Handisurya A et al : Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck. Head Neck. 2003 Jun:25(6): 464-474.
DOI
ScienceOn
|
5 |
Sedivy R. Mannagetta JB. Battistutti W et al : Exression of vascular endothelial growth factor-C correlates with the lymphatic microvessel density and the nodal status un oral squamous cell cancer. J Oral Pathol Med. 2003 Oct 15: 146(2) 455-460.
|
6 |
Brychtova S, Bezdekova M, Brychta T et al : The role of vascular endothelial growth factors and their receptors in malignant melanomas. Neoplasma 55(4) : 273, 2008.
|
7 |
Tanaka K, Miki C, Wakuda R et al : Circulating level of hepatocyte growth factor as a useful tumor marker in patient with early-stage gastric carcinoma. Scand L Gastroenterol 39 : 754. 2004.
DOI
ScienceOn
|
8 |
Cao R, Bjorndahl MA. Religa P et al : PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell 6 : 333, 2004.
DOI
ScienceOn
|
9 |
Chang LK, Garcia-Cardena G, Farnebo F et al : Dosedependent response of FGF-2 for lymphangiogenesis. Proc Natl Acad Sci USA 101 : 11658, 2004.
DOI
ScienceOn
|
10 |
Stiligoi C, de Luca A, Cascone I et al : Angiopoietin-2 expression in breast cancer correlates with lymph node invasion and short survival. Int J Cancer 103 : 466, 2003.
DOI
ScienceOn
|
11 |
Bjorndahl M, Cao R, Nissen LJ et al : Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo. Proc Natl Acad Sci USA 102 : 15593, 2005.
DOI
ScienceOn
|
12 |
Zeng Y, Opeskin K, Baldwin ME et al : Expression of cascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer. Clinical Cancer Reserch 10 : 5137, 2004.
|
13 |
Moser C. Lang SA, Stoeltzing O : The direct effects of anti-vascular endothelial growth factor therapy on tumor cells. Clin Colorectal Cancer 6(8) : 564, 2007.
DOI
ScienceOn
|
14 |
Stacker SA, Achen MG, Jussila L et al : Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2 : 573, 2002.
DOI
ScienceOn
|
15 |
Saharinen P, Tammela T, Karkkainen MJ et a1 : Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation. Trends Immuno 125 : 387, 2004.
|
16 |
Achen MG, Stacker SA : Tumor lymphangiogenesis and metastatic spread - New players begin to emerge. Int J Cancer 119 : 1755, 2006.
DOI
ScienceOn
|
17 |
Pepper MS : Lymphangiogenesis and tumor metastasis: myth or reality? Clin Cancer Res 7 : 462, 2001.
|
18 |
Tang RF, Itakura J. Aikawa T et al : Overexpression of Iymphangiogenic growth factor VEGF-C in human pancreatic cancer. Pancreas 22(3) : 285, 2001.
DOI
ScienceOn
|
19 |
Gee MF, Tsuchida R, Eichler-Jonsson C et al : Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with alltrans-retinoic acid. Oncogene 24(54) : 8025, 2005.
DOI
ScienceOn
|
20 |
Su JL. Yen CJ, Chen PS et al : The role of the VEGFC/VEGFR-3 axis in cancer progression. Br J Cancer 96 : 541, 2007.
DOI
ScienceOn
|
21 |
Valtola R, Salven P, Heikkila Pet al : VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am J PathoI 154(5) : 1381, 1999.
DOI
ScienceOn
|
22 |
Stacker SA, Caesar C, Baldwin ME et al : VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 7 : 186, 2001.
DOI
ScienceOn
|
23 |
Valencak J, Heere-Ress E, Kopp T et al : Selective immunohistochemical staining shows significant prognostic influence of lymphatic and blood vessels in patients with malignant melanoma. Eur J Cancer 40 : 358. 2004.
DOI
ScienceOn
|
24 |
Neuchrist C. Erovic BM, Handisurya A et al : Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Expression in Squamous Cell Carcinomas of the Head and Neck. Laryngoscope 111 : 1834, 2001.
DOI
ScienceOn
|
25 |
Masood R, Cai J, Zheng T et al : Vascular endothelial growth factor(VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors. Blood 98 : 1904, 2001.
DOI
ScienceOn
|
26 |
Wey JS, Stoeltzing O, Ellis LM : Vascular endothelial growth factor receptors: expression and function in solid tumors. Clin Adv Hematol Onco 2(1) : 37, 2004.
|
27 |
Yang AD, Camp ER, Fan F et al : Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transtion in human pancreatic carcinoma cells. Cancer Res 66 : 46, 2006.
DOI
ScienceOn
|
28 |
Weidner N, Semple J, Welch W et al : Tumor angiogenesis and metastasis-correlation in invasive breast cancer. N Engl J Med 324 : 1, 1991.
DOI
ScienceOn
|
29 |
He Y, Rajantie I. Pajusola K. et al : Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res 65 : 4739, 2005.
DOI
ScienceOn
|
30 |
Ohno F, Nacknishi H, Abe A et al : Regional difference in intratumoral Iymphangiogenesis of oral squamous cell carcinoma evaluated by immunohistochemistry using D2-40 and podoplanin antibody: an analysis in comparison with angiogenesis. J Oral Pathol Med 36 : 281, 2007.
DOI
ScienceOn
|
31 |
Schoppmann SF, Eimer P, Stockl J et al : Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Amer J of Pathol 161(3) : 947, 2002.
DOI
ScienceOn
|
32 |
Shintani S. Li C, Ishikawa T et al : Expression of vascular endothelial growth factor A, B, C, and D in oral squamous cell carcinoma. Oral Oncol 40 : 13. 2004.
|
33 |
Gombos Z, Xu X, Chu CS et al : Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early stage squamous cell carcinoma of the uterine cervix. Clin Cancer Res 11 : 8364, 2005.
DOI
ScienceOn
|
34 |
Park YW. Kim SG. Kim SH et al : Gene expression for lymphangiogenic factors in oral mucosal squamous cell carcinoma. J Kor Acad Maxillofac Plast Reconst Surg 31 (6) : 453, 2009.
과학기술학회마을
|
35 |
Van Trappen PO, Steele D, Lowe DG et al : Expression of vascular endothelial growth factor (VEGF)-C and VEGFD, and their receptor VEGFR-3, during different stages of cervical carcinogenesis. J Pathol 201 : 544, 2003.
DOI
ScienceOn
|
36 |
Witte D, Thomas A, Ali N et al : Expression of the vascular endothelial growth factor receptor-3(VEGFR-3) and its ligand VEGF-C in human colorectal adenocacinama. Anticancer Res 22(3) : 1463, 2002.
|